eLux Medical Overview
- Year Founded
-
2013
- Status
-
Private
- Latest Deal Type
-
2ndary - Private
- Investors
-
2
eLux Medical General Information
Description
Developer of nanoparticle technology designed to improve liposuction and aesthetic medicine procedures. The company's technology utilizes a proprietary injectable technology of gold nanoparticles and laser-activated photothermal pretreatment, offering fat removal and skin tightening, enabling plastic surgeons to perform more efficient liposuction with enhanced aesthetic outcomes.
Contact Information
Website
www.eluxmed.comCorporate Office
- 3640 Concord Pike
- Unit 1072
- Saint Thomas, VI 00802
- United States
Corporate Office
- 3640 Concord Pike
- Unit 1072
- Saint Thomas, VI 00802
- United States
eLux Medical Timeline
eLux Medical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Secondary Transaction - Private | 01-May-2026 | Completed | Pre-Clinical Trials | |||
| 6. Later Stage VC (Series B) | 19-Dec-2025 | Completed | Startup | |||
| 5. Accelerator/Incubator | Completed | Startup | ||||
| 4. Accelerator/Incubator | 04-May-2015 | Completed | Startup | |||
| 3. Accelerator/Incubator | 10-Dec-2014 | Completed | Startup | |||
| 2. Angel (individual) | 18-Aug-2014 | $250K | $250K | Completed | Startup | |
| 1. University Spin-Out | 01-Jan-2013 | Completed | Startup |
eLux Medical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B-1 | ||||||||
| Series B | ||||||||
| Series A | 1,422,900 | $0.000100 | 6% | $1 | $1 | 1x | $1 | 4.85% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
eLux Medical Patents
eLux Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12582471-B1 | Gold particles and uses thereof | Active | 24-Sep-2024 | ||
| US-20260083500-A1 | Gold particles and uses thereof | Active | 24-Sep-2024 | ||
| US-20260256517-A1 | Gold particles and uses thereof | Pending | 24-Sep-2024 | ||
| WO-2026072627-A1 | Gold particles and uses thereof | Pending | 24-Sep-2024 | ||
| JP-2015515915-A | Fine space-time control of thermolysis and repolisis using nir light | Inactive | 08-May-2012 | A61K33/242 |
eLux Medical Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| University of California, San Diego | University | |||
| CONNECT (San Diego) | Accelerator/Incubator |
eLux Medical FAQs
-
When was eLux Medical founded?
eLux Medical was founded in 2013.
-
Where is eLux Medical headquartered?
eLux Medical is headquartered in Saint Thomas, VI.
-
What industry is eLux Medical in?
eLux Medical’s primary industry is Other Devices and Supplies.
-
Is eLux Medical a private or public company?
eLux Medical is a Private company.
-
What is eLux Medical’s current revenue?
The current revenue for eLux Medical is .
-
How much funding has eLux Medical raised over time?
eLux Medical has raised $10.3M.
-
Who are eLux Medical’s investors?
University of California, San Diego and CONNECT (San Diego) have invested in eLux Medical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process